Investing Ideas
/
Global High Growth Potential Companies

Global High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

8550

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

8,550 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
SKS SKS Technologies Group	AU$2.22	1.4%	707.3%	AU$248.8m	AU$2.15	PE37.6x	E24.8%	0.5%	Capital Goods
WAYS Waystream Holding	SEK 16.34	3.0%	-40.9%	SEK 131.9m	SEK 36.50	PS1.1x	E113.3%	0%	Tech
RHM Rheinmetall	€705.40	7.7%	117.0%	€30.6b	€725.20	PE44.7x	E29.9%	0.8%	Capital Goods
MBTN Meyer Burger Technology	CHF 2.27	3.2%	-97.5%	CHF 70.0m	CHF 6.03	PS0.8x	E109.3%	n/a	Semiconductors
ICOP I.CO.P.. Società Benefit	€8.04	-3.1%	n/a	€222.2m	€9.80	PE44x	E49.2%	n/a	Capital Goods
AGP Altea Green Power	€6.06	-4.7%	-34.4%	€104.9m	€12.85	PE15.5x	E22.1%	n/a	Capital Goods
ACE Ascelia Pharma	SEK 3.16	11.5%	-53.8%	SEK 303.2m	SEK 8.25	PB2.8x	E47.2%	n/a	Pharmaceuticals & Biotech
GUINNESS Guinness Nigeria	₦70.00	7.7%	-1.1%	₦153.3b	₦74.24	PS0.4x	E116.7%	0%	Food, Beverage & Tobacco
CADLR Cadeler	NOK 57.60	-0.2%	21.6%	NOK 20.2b	NOK 82.10	PE188.3x	E70.9%	n/a	Capital Goods
INIT Initiator Pharma	SEK 7.00	-2.8%	-20.6%	SEK 392.9m	SEK 22.50	PB16.3x	E31.7%	n/a	Pharmaceuticals & Biotech
ELABS Elliptic Laboratories	NOK 10.82	3.6%	-34.4%	NOK 1.1b	NOK 19.00	PS12.2x	E121.1%	n/a	Software
MVW M Vest Water	NOK 8.75	-3.8%	1.3%	NOK 286.3m	NOK 11.70	PS15x	E71.7%	n/a	Materials
AFISH Arctic Fish Holding	NOK 69.50	-4.1%	15.8%	NOK 2.2b	NOK 83.50	PE67.4x	E66.5%	n/a	Food, Beverage & Tobacco
PHM Pharma Mar	€80.55	6.6%	102.3%	€1.4b	€84.40	PE2254.1x	E56.1%	0.8%	Pharmaceuticals & Biotech
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E	ج.م3.33	0.9%	75.3%	ج.م5.0b	ج.م5.02	PE18.8x	E30.7%	2.0%	Pharmaceuticals & Biotech
NEWBRY Newbury Pharmaceuticals	SEK 3.52	3.5%	-27.1%	SEK 85.4m	SEK 8.00	PS2.3x	E130.0%	n/a	Pharmaceuticals & Biotech
RCEL AVITA Medical	US$8.73	-1.8%	-42.0%	US$228.6m	US$17.34	PS3.8x	E51.8%	n/a	Pharmaceuticals & Biotech
ARES Ares Management	US$194.72	8.7%	65.7%	US$59.9b	US$188.92	PE90.9x	E38.4%	1.9%	Diversified Financials
GAU Galiano Gold	CA$1.62	-8.5%	36.1%	CA$395.9m	CA$3.47	PS1.7x	E107.8%	n/a	Materials
ALNY Alnylam Pharmaceuticals	US$264.99	10.2%	39.7%	US$31.8b	US$299.71	PS16.3x	E56.7%	n/a	Pharmaceuticals & Biotech
PRL Propel Holdings	CA$36.17	5.6%	112.9%	CA$1.4b	CA$45.03	PE22.5x	E38.9%	1.6%	Diversified Financials
TVTX Travere Therapeutics	US$19.46	14.0%	109.5%	US$1.6b	US$28.13	PS8.3x	E61.9%	n/a	Pharmaceuticals & Biotech
ALKT Alkami Technology	US$35.76	3.1%	49.1%	US$3.6b	US$45.10	PS11.4x	E102.7%	n/a	Software
KINS Kingstone Companies	US$15.99	11.6%	494.4%	US$189.8m	US$18.00	PE12.4x	E24.9%	0%	Insurance

Page 1 of 357